US Patent Issued to BASF AS on Nov. 11 for "Substituted fatty acids for treating non-alcoholic steatohepatitis" (Norwegian Inventors)

ALEXANDRIA, Va., Nov. 11 -- United States Patent no. 12,465,580, issued on Nov. 11, was assigned to BASF AS (Oslo, Norway).

"Substituted fatty acids for treating non-alcoholic steatohepatitis" was invented by Hilde Steineger (Oslo, Norway), David Alan Fraser (Blommenholm, Norway) and Tore Skjaeret (Oslo, Norway).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to a method of preventing and/or treating non-alcoholic steatohepatitis in a subject in need thereof, comprising administering to the subject a pharmaceutically effective amount of a compound of Formula (II): wherein R1, R2, R3, X and Y are as defined in the specification; or a pharmaceutically acceptable salt, solvate, or s...